Market Research Reports, Inc. has announced the addition of “PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022” research report to their offering. See more at: http://mrr.cm/ZSj

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: February 28, 2014
 Number of Pages: 328
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 9,995
Price For Site User License: USD 19,990
Price For Global User License: USD 29,985
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
During the forecast period from 2012–2022, the growth of
the UC market will be driven largely by the entry of
Johnson & Johnson’s (J&J’s) Simponi and Takeda’s
Entyvio, which will lead to an increase in the overall
number of patients being treated with biologics in the
US, 5EU, Japan, and Canada.

4. www.MarketResearchReports.com
Research Finding
The global ulcerative colitis (UC) market value will increase
steadily over the coming years, growing from almost $4.2 billion
in 2012 to approximately $6.6 billion by 2022, at a Compound
Annual Growth Rate (CAGR) of 4.7%, according to a new report
from research and consulting firm by Publisher.
Johnson & Johnson (J&J) has been continually dominating the
UC market due to the success of Remicade. However, Remicade’s
patent is set to expire between 2015 and 2018, which will knock
J&J’s sales down from approximately $2 billion in 2012 to $1.5
billion by 2022, according to Publisher.
Another key player in the UC industry, AbbVie’s Humira, will
also lose its patent during the forecast period, with sales slipping
from $1.2 billion in 2012 to $569 million by 2022.
However, the UC market will receive a major boost with the
entry of J&J’s Simponi and Takeda’s Entyvio, with sales expected
to reach an estimated $576 million and $1.3 billion by
2022, respectively.

5. www.MarketResearchReports.com
Scope
Overview of UC, including epidemiology, etiology,
pathophysiology, symptoms, diagnosis, and current treatment
options.
Annualized UC therapeutics market revenue, annual cost of
therapy and treatment usage pattern data from 2012 to 2022.
Key topics covered include strategic competitor assessment,
market characterization, unmet needs, and implications for the
UC therapeutics markets.
Pipeline analysis: comprehensive data split across different
phases, emerging novel trends under development, and detailed
analysis of late stage pipeline drugs.
Analysis of the current and future market competition in the
global UC therapeutics markets. Insightful review of the key
industry drivers, restraints and challenges. Each trend is
independently researched to provide qualitative analysis of its
implications.

6. www.MarketResearchReports.com
Reasons to Buy
Develop and design in-licensing and out-licensing strategies
through a review of pipeline products and technologies, and by
identifying the companies with the most robust pipeline.
Additionally a list of acquisition targets included in the pipeline
product company list.
Develop business strategies by understanding the trends
shaping and driving the global UC therapeutics markets.
Drive revenues by understanding the key trends, innovative
products and technologies, market segments, and companies
likely to impact the global UC therapeutics markets in the future.
Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analyzing the
performance of various competitors.

7. www.MarketResearchReports.com
Report Coverage
1. Table of Contents
2. Introduction
3. Disease Overview
4. Epidemiology
5. Disease Management
6. Competitive Assessment
7. Opportunity and Unmet Need
8. Pipeline Assessment
9. Current and Future Players
10.Market Outlook
11.Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

8. www.MarketResearchReports.com
Company Coverage
1. Johnson & Johnson
2. AbbVie
3. Takeda Pharmaceuticals
4. Warner Chilcott
5. Salix Pharmaceuticals/Santarus
6. Shire Pharmaceuticals
7. Ferring Pharmaceuticals
8. Pfizer
9. InDeX Pharmaceuticals
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry
professional, entrepreneur, venture capitalist, investors
and organization, then let us know your specific
research requirements. Our goal is to cater to your
requirements be it for a custom market research
project, syndicated research report on a specific market
or industry sector, newsletter creation, case study
development or anything else related to marketing
research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/ZSj
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)